Paul Walter serves as Executive at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/, where they oversee executive responsibilities. Since joining the company, Paul Walter has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 16, 2018 involved receiving (via award) 1,084 shares valued at $3.8K.
Paul Walter currently holds 13,619 shares of ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Walter has been a net neutral trader of HRT stock. They have purchased $0 and sold $0 worth of shares.
Paul Walter's most recent insider trade was on Aug 16, 2018, when they sold 1,084 shares at $3.46 per share.
Get notified when new Form 4 filings are submitted
| $3.79 |
| Discretionary |
| Feb 15, 2018 | MICR | $3.7K | Award | 1,068 | $3.51 | Discretionary |
| Nov 15, 2017 | MICR | $3.7K | Award | 1,019 | $3.68 | Discretionary |
| Sep 29, 2017 | MICR | $3.8K | Award | 987 | $3.80 | Discretionary |
| Sep 29, 2017 | MICR | $3.7K | Award | 942 | $3.98 | Discretionary |
| Jan 4, 2016 | HRT | $25.6K | Option Exercise | 7,500 | $3.41 | Discretionary |
| Dec 2, 2013 | HRT | $0 | Award | 6,000 | $N/A | Discretionary |